One of the stocks to have emerged as a strong mover over the course of the past month is that of Adamis Pharmaceuticals Corporation (NASDAQ:ADMP).
During the course of the past month, the stock has managed to clock gains of as much as 64% and in light of such considerable gains; it might be the right time for investors to look into Adamis. In this regard, it might be a good move for investors to take a closer look at the letter that was issued to shareholders by the company. In the letter, the company urged the shareholders to vote for the re-election of all the five members of the board at Adamis at the annual meeting of shareholders.
The meeting is going to be held on July 16. In this regard, it should be noted that the company pointed out that continuity at the board level is essential for the success of its COVID 19 medicine Tempol. In the letter, the company stated that board continuity will make sure the product is progressed well and the Phase 2/3 trial for the Tempol could also be initiated. Investors could consider keeping the Adamis stock in their watch lists at this point.
Market Reaction:
On Tuesday, ADMP stock fell 4.20% to $1.15 with more than 5.93 million shares, compared to its average volume of 8.52 million shares. The stock has moved within a range of $1.1000 – 1.1998 after opening the trade at $1.19. Over the past 52-week, the stock has been trading within a range of $0.3800 – 2.3400.
 Stock Consolidates After The Big Jump){kind=link}